StrokePub Date : 2025-01-24DOI: 10.1161/STROKEAHA.124.047070
Dearbhla M Kelly, Eoin M Kelleher, Peter M Rothwell
{"title":"The Kidney-Immune-Brain Axis: The Role of Inflammation in the Pathogenesis and Treatment of Stroke in Chronic Kidney Disease.","authors":"Dearbhla M Kelly, Eoin M Kelleher, Peter M Rothwell","doi":"10.1161/STROKEAHA.124.047070","DOIUrl":"https://doi.org/10.1161/STROKEAHA.124.047070","url":null,"abstract":"<p><p>Cardiovascular diseases such as stroke are a major cause of morbidity and mortality for patients with chronic kidney disease (CKD). The underlying mechanisms connecting CKD and cardiovascular disease are yet to be fully elucidated, but inflammation is proposed to play an important role based on genetic association studies, studies of inflammatory biomarkers, and clinical trials of anti-inflammatory drug targets. There are multiple sources of both endogenous and exogenous inflammation in CKD, including increased production and decreased clearance of proinflammatory cytokines, oxidative stress, metabolic acidosis, chronic and recurrent infections, dialysis access, changes in adipose tissue metabolism, and disruptions in intestinal microbiota. This review focuses on the mechanisms of inflammation in CKD, dialysis and associated therapies, its proposed impact on stroke pathogenesis and prognosis, and the potential role of anti-inflammatory agents in the prevention and treatment of stroke in patients with CKD.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-13DOI: 10.1161/STROKEAHA.124.048067
Haroon Khawar, Spencer McFarlane, Richard B Libman
{"title":"Stroke Mimics at 30 Years: Where We Have Been, Where We Are Now, and Where We Are Going.","authors":"Haroon Khawar, Spencer McFarlane, Richard B Libman","doi":"10.1161/STROKEAHA.124.048067","DOIUrl":"https://doi.org/10.1161/STROKEAHA.124.048067","url":null,"abstract":"<p><p>Stroke mimics and chameleons remain a major challenge to the clinician and clinical investigator. Misdiagnosis of stroke can result in significant harm to our patients, as well as unnecessary financial costs to the health care systems internationally. The approach to stroke mimics and chameleons has evolved over time with the development of clinical scales and technology. The combination of these tools with clinical acumen can minimize diagnostic errors to the benefit of patients.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-08DOI: 10.1161/STROKEAHA.124.048280
Johanna M Ospel, Bijoy K Menon
{"title":"Evolution of Imaging Techniques in Ischemic Stroke.","authors":"Johanna M Ospel, Bijoy K Menon","doi":"10.1161/STROKEAHA.124.048280","DOIUrl":"https://doi.org/10.1161/STROKEAHA.124.048280","url":null,"abstract":"","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142955453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-02DOI: 10.1161/STROKEAHA.124.049307
Jenny P Tsai, Thanh N Nguyen, Deep K Pujara, Johanna T Fifi, Sophia Sundararajan, Joanna D Schaafsma, Natalia Pérez de la Ossa, Michael G Abraham, Michael Chen, Muhammad S Hussain, Santiago Ortega-Gutierrez, Hannah T Johns, Kelsey R Duncan, Leonid Churilov, Colleen G Lechtenberg, Sabreena J Slavin, Amanda Opaskar, Mercedes de Lera, Blanca Lara-Rodriguez, Helena Quesada, Lauren E Fournier, Dana M Defta, Faris Shaker, Clark W Sitton, Anjail Z Sharrief, James C Grotta, Michael D Hill, Marc Ribo, Ameer E Hassan, Bruce C V Campbell, Cathy Sila, Stavropoula I Tjoumakaris, Amrou Sarraj
{"title":"Sex-Based Differences in Endovascular Thrombectomy Outcomes for Large Ischemic Stroke: A SELECT2 Subanalysis.","authors":"Jenny P Tsai, Thanh N Nguyen, Deep K Pujara, Johanna T Fifi, Sophia Sundararajan, Joanna D Schaafsma, Natalia Pérez de la Ossa, Michael G Abraham, Michael Chen, Muhammad S Hussain, Santiago Ortega-Gutierrez, Hannah T Johns, Kelsey R Duncan, Leonid Churilov, Colleen G Lechtenberg, Sabreena J Slavin, Amanda Opaskar, Mercedes de Lera, Blanca Lara-Rodriguez, Helena Quesada, Lauren E Fournier, Dana M Defta, Faris Shaker, Clark W Sitton, Anjail Z Sharrief, James C Grotta, Michael D Hill, Marc Ribo, Ameer E Hassan, Bruce C V Campbell, Cathy Sila, Stavropoula I Tjoumakaris, Amrou Sarraj","doi":"10.1161/STROKEAHA.124.049307","DOIUrl":"https://doi.org/10.1161/STROKEAHA.124.049307","url":null,"abstract":"<p><strong>Background: </strong>Several social and biological factors are shown to differentially affect stroke outcomes between men and women. We evaluated whether clinical outcomes and endovascular thrombectomy (EVT) treatment effects differed between the sexes in patients presenting with large ischemic stroke.</p><p><strong>Methods: </strong>The SELECT2 trial (A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke) was a randomized controlled trial assessing the efficacy and safety of EVT in patients with large strokes across the United States, Canada, Europe, Australia, and New Zealand between October 2019 and September 2022. In this subanalysis, baseline characteristics and clinical and imaging outcomes were compared between women and men, each further divided into cohorts receiving medical treatment without and with EVT. Functional outcomes at 90-day and 1-year follow-ups were assessed using regression models, adjusting for potential confounders. Sex-related effect modification was examined.</p><p><strong>Results: </strong>Women accounted for 145 (41%) of 352 patients enrolled in the SELECT2 trial. Seventy-one (49%) of 145 women and 109 (53%) of 207 men underwent EVT. Endovascular intervention was associated with better functional outcomes (women: adjusted generalized odds ratio, 1.73 [1.22-2.45]; men: adjusted generalized odds ratio, 1.66 [1.24-2.23]; <i>P</i>-int: 0.94), functional independence (women: EVT, 20% versus medical management, 4%; adjusted risk ratio [aRR], 5.04 [1.59-16.02]; men: EVT, 20% versus medical management, 9%; aRR, 1.99 [0.99-4.02]; <i>P</i>-int: 0.20), and independent ambulation (women: EVT, 39% versus medical management, 16%; aRR, 2.44 [1.40-4.24]; men: EVT, 38% versus medical management, 20%; aRR, 1.98 [1.29-3.03]; <i>P</i>-int: 0.67) in both men and women at 90-day follow-up, without significant heterogeneity. Similar results were observed at 1-year follow-up. In women, as age increased (aRR, 0.97 [95% CI, 0.95-0.99]; <i>P</i>=0.004 per year) and core volume estimates increased (aRR, 0.99 [95% CI, 0.98-1.00]; <i>P</i>=0.015 per mL increase), the rate of independent ambulation after EVT decreased. A similar association of age and core volume was seen in men.</p><p><strong>Conclusions: </strong>EVT treatment benefit was maintained in both women and men, with higher rates of functional independence and independent ambulation as compared with medical management. Age and estimated core infarct volume were independently associated with independent ambulation in both male and female patients. EVT should be equally considered for patients of both sexes meeting large core eligibility criteria.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT03876457.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":7.8,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-01Epub Date: 2024-12-20DOI: 10.1161/STROKEAHA.124.045754
Elizabeth Lorenzi, Amy M Crawford, Craig S Anderson, Bijoy Menon, Xiaoying Chen, Eva Mistry, Pooja Khatri, Jordan J Elm, Jonathan Beall, Benjamin R Saville, Scott M Berry, Roger J Lewis
{"title":"Adaptive Platform Trials in Stroke.","authors":"Elizabeth Lorenzi, Amy M Crawford, Craig S Anderson, Bijoy Menon, Xiaoying Chen, Eva Mistry, Pooja Khatri, Jordan J Elm, Jonathan Beall, Benjamin R Saville, Scott M Berry, Roger J Lewis","doi":"10.1161/STROKEAHA.124.045754","DOIUrl":"10.1161/STROKEAHA.124.045754","url":null,"abstract":"<p><p>Clinical trials of treatments for stroke have generally utilized 2-arm, randomized designs to evaluate a single intervention against a control. Running separate clinical trials, with each addressing a single therapeutic question, is resource intensive and slows evidence generation, especially in a field with rapidly expanding treatment options and evolving practices. Platform trials-randomized clinical trials designed to evaluate multiple interventions that may enter and exit the ongoing platform based on a master protocol-accelerate the investigation of multiple therapeutic options within a single infrastructure. This in turn has the potential to accelerate access to new interventions for patients with stroke that can save lives and improve outcomes. In the context of acute ischemic stroke, 2 new platform trials have been established, the STEP trial (StrokeNet Thrombectomy Endovascular Platform) and ACT-GLOBAL (A Multi-Factorial, Multi-Arm, Multi-Stage, Randomised, Global Adaptive Platform Trial for Stroke), to address multiple therapeutic questions simultaneously using a multifactorial design including Bayesian modeling and other adaptive features. These trials are designed to maximize the information obtained from each participant, to align clinical research more closely with the complexities of clinical care, and to accelerate the identification of effective therapies. This article explores conceptual, practical, and statistical considerations in the design and implementation of adaptive platform trials and highlights their potential to accelerate the identification of new therapies, management, and rehabilitation in stroke.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":"56 1","pages":"198-208"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11665893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142869671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-01Epub Date: 2024-11-27DOI: 10.1161/STROKEAHA.124.049116
Sophia R McMorrow, Sung Min Park, Tessa G George, Chloe M Sobolewski, Dalin Yang, Kelsey T King, Jeanette Kenley, Christopher D Smyser, Joseph P Culver, Kristin P Guilliams, Ahmed S Said, Adam T Eggebrecht
{"title":"Bedside Neuroimaging Using High-Density Diffuse Optical Tomography in a Pediatric Patient on Extracorporeal Support.","authors":"Sophia R McMorrow, Sung Min Park, Tessa G George, Chloe M Sobolewski, Dalin Yang, Kelsey T King, Jeanette Kenley, Christopher D Smyser, Joseph P Culver, Kristin P Guilliams, Ahmed S Said, Adam T Eggebrecht","doi":"10.1161/STROKEAHA.124.049116","DOIUrl":"10.1161/STROKEAHA.124.049116","url":null,"abstract":"","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":"e3-e5"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11665966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142732844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-01Epub Date: 2024-12-09DOI: 10.1161/STROKEAHA.124.049147
Olivier Godefroy, Niels Trinchard, Etienne Marchal, Chantal Lamy, Sandrine Canaple, Marc-Etienne Meyer, Martine Roussel, Frank A Wollenweber
{"title":"Do Amyloid Cerebral Deposits Influence the Long-Term Poststroke Cognitive Outcome?: The IDEA3 Study.","authors":"Olivier Godefroy, Niels Trinchard, Etienne Marchal, Chantal Lamy, Sandrine Canaple, Marc-Etienne Meyer, Martine Roussel, Frank A Wollenweber","doi":"10.1161/STROKEAHA.124.049147","DOIUrl":"10.1161/STROKEAHA.124.049147","url":null,"abstract":"<p><strong>Background: </strong>Although the presence of amyloid deposits is associated with a more severe cognitive status in patients with stroke at baseline, its influence on the subsequent cognitive outcome has not been extensively assessed. The primary objective of the present study of the IDEA3 (Imagerie des dépôts amyloïdes cérébraux par florbetapir AV-45 et diagnostic des déficits cognitifs et démence post Accident Vasculaire Cérébral) cohort was to determine the influence of amyloid positron emission tomography (PET) status on the 5-year cognitive outcome.</p><p><strong>Methods: </strong>This longitudinal study performed in Amiens University Hospital (inclusions: October 2014 to October 2019; last visits: October 2018 to February 2023) has included 91 patients with stroke (ischemic stroke, 89%; hemorrhagic stroke, 11%) with florbetapir PET data at baseline (positive, n=14). Patients underwent annually comprehensive clinical and cognitive assessments for 5 years after the PET scan. The primary outcome was incident dementia; secondary outcomes were incident cognitive impairment, total prevalence of cognitive impairment, and modified Rankin Scale score.</p><p><strong>Results: </strong>A survival analysis (mean poststroke follow-up, 80.4±27 months) showed that the incidence of incident dementia was higher in the PET-positive patients (odds ratio, 9.6 [95% CI, 2.5-36.9]; <i>P</i>=0.001), as was the incidence of incident cognitive impairment (odds ratio, 10 [95% CI, 1.9-52.3]; <i>P</i>=0.003). A Cox regression analysis showed that the association between amyloid status and the incidences of dementia (<i>P</i>=0.001) and cognitive impairment (<i>P</i>=0.007) was still significant after adjustment for age, education, prestroke modified Rankin Scale score and cognitive impairment, stroke type, and the PET status×stroke type interaction. Considering the overall prevalence at the last follow-up in the whole study population (n=91 patients), PET positivity was associated with an elevated risk of dementia (odds ratio, 6 [95% CI, 1.76-20.5]; <i>P</i>=0.002) and poststroke cognitive impairment (odds ratio, 6.25 [95% CI, 1.77-22]; <i>P</i>=0.002). The final modified Rankin Scale score did not differ (<i>P</i>=0.3) according to PET status.</p><p><strong>Conclusions: </strong>Our results demonstrate the major impact of amyloid deposition on the stroke outcome and emphasized the need for comprehensive etiologic workup in patients with poststroke cognitive impairment.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT02813434.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":"74-83"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142795160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-01Epub Date: 2024-12-05DOI: 10.1161/STROKEAHA.124.048380
Sigrid Breinholt Vestergaard, Jan Brink Valentin, Christina C Dahm, Hanne Gottrup, Søren P Johnsen, Grethe Andersen, Janne Kærgård Mortensen
{"title":"Socioeconomic Disparities in Rate of Poststroke Dementia: A Nationwide Cohort Study.","authors":"Sigrid Breinholt Vestergaard, Jan Brink Valentin, Christina C Dahm, Hanne Gottrup, Søren P Johnsen, Grethe Andersen, Janne Kærgård Mortensen","doi":"10.1161/STROKEAHA.124.048380","DOIUrl":"10.1161/STROKEAHA.124.048380","url":null,"abstract":"<p><strong>Background: </strong>Socioeconomic disparities exist in acute stroke care as well as in long-term stroke outcomes. We aimed to investigate whether socioeconomic status was associated with the rate of poststroke dementia (PSD).</p><p><strong>Methods: </strong>This was a nationwide register-based cohort study including all patients with incident ischemic or hemorrhagic stroke in Denmark from 2010 to 2020. Socioeconomic status was defined by prestroke income, education, and employment. PSD was defined as a dementia diagnosis in the National Patient Registry or a dispensed prescription of dementia medication after a stroke. PSD incidence rates were compared between socioeconomic status groups using Poisson regression.</p><p><strong>Results: </strong>A total of 98 489 patients with incident stroke without a diagnosis of prestroke dementia were identified and followed for a median (IQR) of 4.2 (IQR, 2.1-7.3) years. Median age was 72 (62-80) years, 56% were male, 5.1% were immigrants, and 86% had ischemic stroke. Dementia was diagnosed in 5680 patients at a median of 2.4 (IQR, 0.9-4.8) years after stroke (incidence rate=12.1/1000 person-years). After adjusting for age, sex, and immigrant status, PSD rates were 1.24 (1.15-1.34) times higher for low income compared with high income, 1.11 (1.03-1.20) times higher for low education compared with high education, and 1.57 (1.38-1.77) times higher for patients without employment compared with patients with employment. Further adjustments for stroke severity, cohabitation, and comorbidities showed similar results. Stratified analyses showed that the socioeconomic disparities in PSD rates were more pronounced among women, immigrants, and patients <70 years of age.</p><p><strong>Conclusions: </strong>Low socioeconomic status measured by prestroke income, education, and employment status was associated with higher rates of PSD. These socioeconomic disparities extended beyond what could be explained by common PSD risk factors.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":"65-73"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2025-01-01Epub Date: 2024-12-05DOI: 10.1161/STROKEAHA.124.048637
Gabriel Broocks, Mahmoud Mannoun, Matthias Bechstein, Helge Kniep, Laurens Winkelmeier, Gerhard Schön, Christian Heitkamp, Panagiotis Papanagiotou, Andre Kemmling, Karsten Alfke, Jens Fiehler, Lukas Meyer
{"title":"Penumbral Imaging to Guide Endovascular Treatment for M2 Middle Cerebral Artery Stroke.","authors":"Gabriel Broocks, Mahmoud Mannoun, Matthias Bechstein, Helge Kniep, Laurens Winkelmeier, Gerhard Schön, Christian Heitkamp, Panagiotis Papanagiotou, Andre Kemmling, Karsten Alfke, Jens Fiehler, Lukas Meyer","doi":"10.1161/STROKEAHA.124.048637","DOIUrl":"10.1161/STROKEAHA.124.048637","url":null,"abstract":"<p><strong>Background: </strong>A potential benefit of mechanical thrombectomy for patients with distal medium vessel occlusions is currently being investigated in randomized trials. Computed tomography perfusion imaging has not yet been tested as a method to guide mechanical thrombectomy for distal medium vessel occlusions. The purpose of this study was to assess penumbral imaging as an imaging-based method for triaging patients with ischemic stroke and acute M2-middle cerebral artery occlusion.</p><p><strong>Methods: </strong>This observational retrospective study of M2-middle cerebral artery patients with ischemic stroke triaged by multimodal computed tomography undergoing mechanical thrombectomy at a high-volume stroke center between January 2015 and January 2023. The effect of recanalization was analyzed according to computed tomography perfusion-derived lesion volumes (defined using relative cerebral blood flow <30% and <i>T</i><sub>max</sub> >6 seconds) using logistic regression analysis, and interaction terms between the independent variables and recanalization were tested. The primary end point was functional independence at day 90, defined using modified Rankin Scale scores of 0 to 2.</p><p><strong>Results: </strong>A total of 140 patients with M2-middle cerebral artery occlusion were included. In multivariable logistic regression analysis, recanalization was not associated with better functional outcome (adjusted odds ratio, 1.85 [95% CI, 0.87-3.90]; <i>P</i>=0.11). After including interaction terms, a significant treatment effect between recanalization and computed tomography perfusion-derived lesion volumes was observed in patients with >150 mL hypoperfusion volume (adjusted odds ratio, 1.02 [95% CI, 1.00-1.03]; <i>P</i>=0.007) or >125 mL penumbral volumes (adjusted odds ratio, 1.02 [95% CI, 1.01-1.03]; <i>P</i>=0.005), as well as for baseline ischemic core volume within the range of 15 to 40 mL (adjusted odds ratio, 1.11 [95% CI, 1.01-1.22]; <i>P</i>=0.03).</p><p><strong>Conclusions: </strong>Penumbral imaging might serve as a useful tool for treatment decision-making in distal medium vessel occlusions, particularly in cases of suspected non- or codominant M2-middle cerebral artery vessel occlusions. A hypoperfusion volume threshold of >150 mL emphasizes the potential value of computed tomography perfusion as a standardized tool directly showing the volumetric relevance in distal medium vessel occlusion cases.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":"138-147"},"PeriodicalIF":7.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142781104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}